Remove Blog Remove Government Remove Provider Remove Screening
article thumbnail

Logistics Unwrapped: A Roadmap to Successful FDA Meetings in In-Person and Hybrid Formats

FDA Law Blog

For example, device sponsors can request a meeting with an FDA review team by submitting a pre-submission to CDRH (see our recent blog on the minor updates to the Pre-Submission Guidance). Once your request for an in-person or hybrid meeting is agreed upon, you are expected to provide a list of in-person and virtual attendees.

article thumbnail

Update on CDER, CBER, and CDRH Meetings with Industry

FDA Law Blog

The pandemic also deeply impacted how industry and the government conduct their operations. A teleconference will be conducted by voice only with no projection of presentations or use of video/camera; a videoconference would involve sharing a screen so that a presentation can be viewed by all participants and/or involve the use of video.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Welcome to SRP-RMT – Standardization Comes to Regenerative Medicine Therapies?

FDA Law Blog

These standards would be developed outside the Federal government, leveraging the expertise of the private sector. These meetings have a question-and-answer format to provide clarity to sponsors about the particular topics at hand.

article thumbnail

Where Are All the OTC Rapid Antigen Tests for COVID? FDA’s Role in Blocking These Tests from the American Market

FDA Law Blog

A positive result, however, is treated as a screen. That is just another way of saying, however, that the rapid antigen tests are best positioned as a screening tool. These tests could have been a valuable screening tool for COVID during the past year or so. A follow up laboratory?run run molecular diagnostic (RT?PCR)